Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.50 |
---|---|
High | 0.50 |
Low | 0.50 |
Bid | 0.468 |
Offer | 0.486 |
Previous close | 0.50 |
Average volume | -- |
---|---|
Shares outstanding | 36.38m |
Free float | 16.69m |
P/E (TTM) | -- |
Market cap | 94.58m USD |
EPS (TTM) | -0.6422 USD |
Data delayed at least 15 minutes, as of Sep 05 2018.
More ▼
Announcements
- Microbot Medical® Added to the Russell Microcap® Index
- Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China
- Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System
- Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index
- Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers
- Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System
- REMINDER: Microbot Medical Announces Data from the Company’s ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting
- Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System
- Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting
- Microbot Medical Closes $13 Million Registered Direct Offering
More ▼